-
The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade.
-
-
Contraceptive injectables are a popular form of birth control for women around the world, with more than 35 million women relying on the method.
-
Since the July 2002 publication of the first Women's Health Initiative (WHI) report, many changes have been made in the approach to hormone therapy (HT).
-
Transient ischemic attacks (TIAs) and minor strokes are often the harbingers of a large, debilitating stroke.
-
Five days of steroid treatment was as effective as 14 days of treatment in preventing repeat exacerbations of COPD in patients presenting to the emergency department with COPD exacerbations.
-
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
-
-
Patients, clinicians, and policy makers are increasingly focused on ways to improve the quality of care delivered and provide support to patients and families at the end of life (EOL).
-
The relationship between neurologic complications of infective endocarditis (IE), urgent valve surgery, and outcomes is poorly understood. Thus, these investigators performed a retrospective analysis of a prospectively collected database of IE cases from 1984-2009 in seven Spanish hospitals.
